The Breast Cancer Now Toby Robins Research Centre brings together world leaders in key research areas and has more than 100 doctors and scientists.
The Breast Cancer Now Toby Robins Research Centre brings together world leaders across key research areas. It has 10 teams and more than 100 doctors and scientists all working together with one aim – to stop women dying from breast cancer. The Centre, formerly known as the Breakthrough Toby Robins Breast Cancer Research Centre, opened at the Institute of Cancer Research, London, in 1999.
The Breast Cancer Now Toby Robins Research Centre has state-of-the-art equipment to allow its scientists to make fast and effective progress in their work. And, importantly, it is closely linked to the renowned cancer research hospital, the Royal Marsden, so findings can be brought to patients as quickly as possible.
The teams are trying to answer the big questions in breast cancer research:
- What causes breast cancer, so we can ultimately prevent it?
- How can we more precisely diagnose the disease so patients receive the right treatment?
- How can we find new, more effective treatments?
- How can we stop secondary breast cancer taking lives?
Since this centre opened we have seen it make many significant discoveries. Our research has contributed to the discovery of a new targeted treatment, the identification of more than half of the known genetic markers for breast cancer risk and helped improve the way that doctors diagnose patients.
None of this would have been possible without the dedication and support of Breast Cancer Now’s fundraisers up and down the country who make this work possible.
The success of the Research Centre has been driven by the inspirational leadership of Professor Alan Ashworth, Director from 1999–2010, Professor Clare Isacke, Interim Director from 2010-2013 and now Director Professor Andrew Tutt. All have shown remarkable commitment to further our progress against this most complex disease.
Research projects at the Breast Cancer Now Toby Robins Research Centre
- Discovering genetic variations within the different types of breast cancer
- Molecular oncology team
- Molecular cell biology team
- Gene function team
- Functional genomics group
- Drug target discovery team
- Cell death and inflammation team
- Endocrinology team
- Breast development team
- Genetic epidemiology group
- Complex trait genetics group
- Predicting which cases of DCIS will progress to invasive breast cancer using the extracellular matrix
- Finding new potential drug targets for aggressive breast cancers